Silicofeller
Industries · Pharma & Life Sciences

From molecular simulation to manufacturing optimisation.

Pharma and biotech leaders worldwide are scaling computational chemistry, generative-AI drug design, and manufacturing-process simulation. Quantum and HPC together change the unit economics of discovery — and ultimately, the speed at which the next generation of medicines reaches patients.

Use Cases

Where quantum and HPC create value in Pharma & Life Sciences.

01 / 04

Computational chemistry on multi-GPU simulators

VQE and quantum chemistry workloads on dedicated CUDA-Q infrastructure for drug-candidate screening and binding-energy estimation.

02 / 04

Generative AI for drug design

Hybrid HPC + quantum pipelines for molecular generation, retrosynthesis, and ADMET prediction.

03 / 04

Manufacturing process optimisation

Stochastic optimisation of fermentation, formulation, and supply-chain workflows using quantum-inspired solvers.

04 / 04

Genomics & translational research HPC

Reference HPC stacks for clinical-grade genomics with privacy-preserving compute fabrics.

Why Silicofeller

Why Pharma & Life Sciences leaders engage us.

  • 01Scientific computing background; not a generalist consultancy.
  • 02Hybrid quantum + HPC pipelines designed for production research workflows.
  • 03Partnerships with academic chemistry groups under formal MoU structures.
Engage

Let's discuss your initiative.

We engage selectively, across a small number of multi-year institutional partnerships at any given time. If your organisation is scoping a quantum or HPC initiative — enterprise, research, or public-sector — we would welcome a direct conversation.

Full Contact Form
Capabilities deck

The full Silicofeller Capabilities Overview.

A six-page PDF briefing — capability lines, platform architecture, industries served, and how we engage. Useful for boards, procurement teams, and technical evaluators.

  • Six capability lines with engineering-grade detail
  • Platform architecture: IQSS, Qubit Pro, Compute Fabric
  • Engagement formats and typical first conversation